Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Treatt PLC on Friday said it has appointed Manprit Randhawa as interim chief financial officer, effective from Monday.
The Suffolk, England-based extracts and ingredients manufacturer confirmed that as previously announced Ryan Govender will step down as director and CFO at the end of September, after completing a handover period to Randhawa.
Treatt said Randhawa will support the company while the process to appoint a permanent replacement continues.
Randhawa will join Treatt’s executive committee but will not be a member of the board. He is joining Treatt from life science firm SkinBioTherapeutics, where he was CFO.
‘We are delighted to welcome Manprit as Interim Chief Financial Officer. He brings a wealth of strategic and commercial expertise to Treatt, and we look forward to working with him,’ said Treatt Chair Vijay Thakrar.
Shares in Treatt were up 0.1% at 228.66 pence in London on Friday morning.
Copyright 2025 Alliance News Ltd. All Rights Reserved.